Axcella Health Inc. (AXLA): Price and Financial Metrics
GET POWR RATINGS... FREE!
AXLA Stock Price Chart Interactive Chart >
AXLA Price/Volume Stats
|Current price||$0.68||52-week high||$2.89|
|Prev. close||$0.63||52-week low||$0.16|
|Day high||$0.68||Avg. volume||1,780,635|
|50-day MA||$0.60||Dividend yield||N/A|
|200-day MA||$1.56||Market Cap||50.02M|
Axcella Health Inc. (AXLA) Company Bio
Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways.
Most Popular Stories View All
AXLA Latest News Stream
|Loading, please wait...|
AXLA Latest Social Stream
View Full AXLA Social Stream
Latest AXLA News From Around the Web
Below are the latest news stories about AXCELLA HEALTH INC that investors may wish to consider to help them evaluate AXLA as an investment opportunity.
Updates from bluebird (BLUE) and Catalyst Pharmaceuticals (CPRX) are the key highlights from the biotech sector during the past week.
Axcella Therapeutics Inc. has one of the most advanced potential drugs for Long Covid in the industry. It also has only enough cash runway to get it through the second quarter of this year, making for a mad-dash effort to get that drug through clinical trials.
Axcella Health (AXLA) stock is rocketing higher on Tuesday after revealing a regulatory path to registration for AXA1125.
LogicMark (LGMK) stock is falling on Tuesday after the medical device company priced a $5.2 million public offering of its shares.
Novo Integrated Sciences (NVOS) stock is taking off on Tuesday despite a lack of news concerning the healthcare company.
AXLA Price Returns